Masimo Corp. (NASDAQ:MASI) CEO Joe E. Kiani sold 49,484 shares of the firm’s stock in a transaction that occurred on Thursday, September 22nd. The shares were sold at an average price of $60.18, for a total transaction of $2,977,947.12. Following the transaction, the chief executive officer now directly owns 158,911 shares of the company’s stock, valued at approximately $9,563,263.98. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Shares of Masimo Corp. (NASDAQ:MASI) opened at 59.16 on Tuesday. Masimo Corp. has a 12-month low of $33.03 and a 12-month high of $60.52. The stock has a market cap of $2.92 billion, a PE ratio of 31.02 and a beta of 0.80. The stock’s 50 day moving average is $58.68 and its 200-day moving average is $50.33.
Masimo Corp. (NASDAQ:MASI) last released its quarterly earnings results on Wednesday, August 3rd. The company reported $0.57 EPS for the quarter, topping analysts’ consensus estimates of $0.41 by $0.16. Masimo Corp. had a net margin of 15.40% and a return on equity of 29.07%. The firm earned $172.64 million during the quarter, compared to analysts’ expectations of $166.02 million. During the same period in the previous year, the company earned $0.36 EPS. The firm’s revenue for the quarter was up 10.9% compared to the same quarter last year. Equities analysts expect that Masimo Corp. will post $2.02 EPS for the current year.
A number of equities analysts have weighed in on MASI shares. Wedbush reaffirmed an “outperform” rating and set a $63.00 target price (up previously from $60.00) on shares of Masimo Corp. in a research note on Thursday, August 4th. Piper Jaffray Cos. reaffirmed an “overweight” rating and set a $55.00 target price (up previously from $52.00) on shares of Masimo Corp. in a research note on Friday, August 5th. BTIG Research reaffirmed a “hold” rating on shares of Masimo Corp. in a research note on Friday, August 5th. Finally, Raymond James Financial Inc. downgraded shares of Masimo Corp. from a “strong-buy” rating to an “outperform” rating in a research note on Wednesday, June 1st. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Masimo Corp. currently has an average rating of “Buy” and an average price target of $52.60.
Several institutional investors have recently added to or reduced their stakes in MASI. Geode Capital Management LLC boosted its position in Masimo Corp. by 0.7% in the first quarter. Geode Capital Management LLC now owns 426,362 shares of the company’s stock worth $17,838,000 after buying an additional 3,002 shares in the last quarter. UBS Group AG boosted its stake in Masimo Corp. by 3.6% in the first quarter. UBS Group AG now owns 19,177 shares of the company’s stock valued at $802,000 after buying an additional 663 shares during the period. State Street Corp boosted its stake in Masimo Corp. by 3.1% in the first quarter. State Street Corp now owns 890,937 shares of the company’s stock valued at $37,271,000 after buying an additional 26,485 shares during the period. Zebra Capital Management LLC boosted its stake in Masimo Corp. by 20.9% in the first quarter. Zebra Capital Management LLC now owns 21,916 shares of the company’s stock valued at $917,000 after buying an additional 3,783 shares during the period. Finally, Spark Investment Management LLC bought a new stake in Masimo Corp. during the first quarter valued at about $2,092,000. 79.88% of the stock is owned by hedge funds and other institutional investors.
About Masimo Corp.
Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring.
Receive News & Ratings for Masimo Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corp. and related companies with MarketBeat.com's FREE daily email newsletter.